#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14478	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2404	738.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1875	1875	T	980	T,A,G	977,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14478	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2404	738.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1609	1609	C	909	C,T	907,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24324	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4022	753.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1950	1950	A	1023	A,G	1022,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24324	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4022	753.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2584	2584	C	805	C,A	803,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24324	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4022	753.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3210	3210	T	839	T,C,A,G	833,2,2,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24324	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4022	753.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2658	2658	A	707	A,C	704,3	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	613	615	GTT	111;110;111	G;T,A;T	111;109,1;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	634	636	AAA	123;124;124	A;A;A	123;124;124	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	691	693	TTG	152;154;156	T;T,G;G,T	152;152,2;155,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	724	726	CAA	197;199;202	C,A;A;A	196,1;199;202	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	823	825	CCT	214;215;215	C,A;C,G;T	213,1;214,1;215	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	859	861	GCA	173;172;175	G,C;C,T,A;A	172,1;170,1,1;175	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	988	990	CTC	180;180;182	C;T;C,T	180;180;181,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	1003	1005	TGT	184;185;187	T;G;T,G	184;185;186,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	1009	1011	GCG	188;190;189	G;C,T;G	188;189,1;189	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1051	1053	AAG	209;206;208	A;A;G	209;206;208	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1054	1056	AAT	209;211;211	A,C;A;T	208,1;211;211	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1252	1254	TTG	133;132;132	T,G;T;G	132,1;132;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1282	1284	AGC	119;119;118	A;G;C	119;119;118	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1351	1353	CTG	119;118;117	C,T;T;G	118,1;118;117	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1357	1359	TCC	116;115;115	T;C;C	116;115;115	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1372	1374	GTG	137;141;142	G,A;T,C;G	136,1;139,2;142	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1592	folP	852	852	93.78	folP.l15.c4.ctg.1	1970	100.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1423	1425	GCG	162;162;157	G,C;C,T;G	161,1;161,1;157	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5242	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3918	166.9	1	SNP	p	S91F	0	.	.	271	273	TCC	885	887	TCC	199;198;197	T;C;C	199;198;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5242	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3918	166.9	1	SNP	p	D95N	0	.	.	283	285	GAC	897	899	GAC	197;198;197	G;A;C	197;198;197	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5242	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3918	166.9	1	SNP	p	D95G	0	.	.	283	285	GAC	897	899	GAC	197;198;197	G;A;C	197;198;197	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1816	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1865	121.2	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	1044	1044	T	214	T,C	213,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	990	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1445	85.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1755	1757	ATC	242;242;241	A,C;T;C	241,1;242;241	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1908	1910	GCA	246;247;249	G,C;C,T,A;A	244,2;245,1,1;249	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	1	SNP	p	D86N	0	.	.	256	258	GAC	861	863	GAC	201;202;201	G,A;A;C,G	200,1;202;200,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	1	SNP	p	S87I	0	.	.	259	261	AGT	864	866	AGT	204;206;205	A;G,T;T	204;205,1;205	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	1	SNP	p	S87W	0	.	.	259	261	AGT	864	866	AGT	204;206;205	A;G,T;T	204;205,1;205	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	1	SNP	p	S87R	0	.	.	259	261	AGT	864	866	AGT	204;206;205	A;G,T;T	204;205,1;205	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4684	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3490	167.2	1	SNP	p	S88P	0	.	.	262	264	TCC	867	869	TCC	205;207;204	T;C;C	205;207;204	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4258	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3115	170.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1757	1759	GGC	226;222;226	G;G,T;C	226;221,1;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1593	1595	GCA	233;233;233	G;C;A	233;233;233	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1596	1598	ATC	230;228;230	A;T,A;C	230;226,1;230	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1608	1610	GTG	219;217;217	G,C;T;G,T	218,1;217;215,2	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1608	1610	GTG	219;217;217	G,C;T;G,T	218,1;217;215,2	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2112	2114	ACC	236;236;236	A;C;C	236;236;236	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2166	2168	GCG	214;214;215	G;C;G,C,A	214;214;213,1,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2166	2168	GCG	214;214;215	G;C;G,C,A	214;214;213,1,1	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2289	2291	GGT	220;219;221	G,T;G;T,A	219,1;219;220,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2298	2300	GGC	221;218;221	G;G,C;C	221;217,1;221	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4028	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2986	168.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2316	2318	CCG	228;233;233	C,G,A;C,T,A;G,T	226,1,1;231,1,1;231,2	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5398	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3659	184.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2304	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2274	126.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	527	529	GGC	155;156;157	G;G;C,A	155;156;156,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2304	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2274	126.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	709	709	C	159	C	159	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	24;26;28	T;T;A	24;26;28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	58;58;58	C;A;T	58;58;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	58;58;58	A;G;T	58;58;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	58;58;58	T;A;C	58;58;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	4;5;5	T;C;G	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	5;6;6	A;G;C	5;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	6;6;6	G;C;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	274	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	313	29.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2812	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1925	180.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1113	1113	T	220	T,G	219,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2812	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1925	180.5	1	SNP	p	G120K	0	.	.	358	360	GGT	840	842	GGT	239;235;238	G;G;T,C	239;235;237,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2812	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1925	180.5	1	SNP	p	A121N	0	.	.	361	363	GCC	843	845	GCC	234;234;234	G,T;C,A;C	233,1;233,1;234	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2812	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1925	180.5	1	SNP	p	A121D	0	.	.	361	363	GCC	843	845	GCC	234;234;234	G,T;C,A;C	233,1;233,1;234	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9930	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5469	226.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1438	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1489	120.4	1	SNP	p	V57M	1	.	.	169	171	ATG	730	732	ATG	251;252;247	A;T;G	251;252;247	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
